An example of this is in RUNX1 FPD-MM, in unaffected individuals with germline RUNX1 variants we do not detect CHIP in RUNX1 however biallelic RUNX1 variants are the most common event associated with malignancy (229). This evidence concerns the gene RUNX1 and Miyoshi myopathy.